NEYT, M.; ALBRECHT, J.; CLARYSSE, B.; COCQUYT, V. - Faculteit Economie en Bedrijfskunde, Universiteit Gent - 2003
Objective: The objective of this study was to set up a standard cost model for breast-cancer treatment to be able to complete a cost-effectiveness analysis of Herceptin®. This is a new biotechnological pharmaceutical developed by Genentech. Herceptin® is a humanized monoclonal antibody that...